Medifast Inc

MED PE Ratio & Price to Earnings Analysis

Live trailing and forward price-to-earnings multiples for MED, with earnings yield, PEG ratio, historical P/E context and how today's multiple compares to what MED has traded at in the past.

$11.77-1.59% todayUSD · live quote

MED P/E Ratio Today

A trailing P/E ratio for MED is unavailable — trailing earnings are negative or not reported.

Forward P/E
—
EPS (TTM)
$-2.33
Earnings yield
—
PEG ratio
—

MED PE Ratio History

Reported price-to-earnings multiple for MED across recent periods, showing whether today's valuation is rich or cheap versus its own track record.

P/E 545.50 P/E 548.50 P/E 548.50 P/E 537.00 P/E 549.50 P/E 550.50 P/E 543.00 P/E 544.00 P/E 568.00 P/E 565.00 P/E 583.00 P/E 591.50 P/E 618.00 P/E 600.00 P/E 601.50 P/E 609.00 P/E 601.50 P/E 592.50 P/E 566.50 P/E 557.50 P/E 564.00 P/E 552.00 P/E 527.00 P/E 527.00
Average P/E
52.11
Lowest P/E
3.15
Highest P/E
701.50
Current vs average
—

MED Earnings & Fundamentals Behind the P/E

The earnings power and growth profile that justify — or fail to justify — the MED multiple.

Market cap
$131.60M
Revenue (TTM)
$76.04M
Revenue growth
-27.6%
EPS growth
—
Net margin
-8.1%
P/E (TTM)
—
Forward P/E
—
PEG ratio
—

Is MED Cheap or Expensive Right Now?

Valuation multiples say what you pay; Z-Scores say how stretched the price is versus its statistical mean. Reading both together separates a cheap multiple from a falling knife.

1H
-1.70
Statistically neutral
4H
0.10
Statistically neutral
1D
0.86
Statistically neutral

How the MED P/E Ratio Is Calculated

The trailing P/E divides the live MED share price by trailing twelve-month diluted earnings per share. The forward P/E uses consensus estimated earnings for the next twelve months. Earnings yield is simply the inverse of the trailing P/E, expressed as a percentage, which makes it directly comparable to a bond yield. The PEG ratio divides the trailing P/E by the expected EPS growth rate to adjust the multiple for growth.

Multiples are only meaningful in context. A P/E is best compared to the company's own history, to sector peers with similar margins, and to the growth actually being delivered. Nothing on this page is investment advice.

MED PE Ratio FAQ

What is the PE ratio of MED?

A trailing P/E for MED cannot be computed right now, typically because trailing earnings are negative or not yet reported.

Is MED overvalued based on its P/E?

Without a reliable historical P/E series for MED, compare the current multiple to sector peers and to the growth rate the company is delivering.

What is a good PE ratio?

There is no universal number. Mature, slow-growing businesses often trade in the low teens, while fast compounders can sustain multiples several times higher. What matters is whether earnings growth justifies the multiple — that is exactly what the PEG ratio measures.

What is the difference between trailing and forward P/E for MED?

Trailing P/E uses the last twelve months of reported earnings; forward P/E uses estimates for the coming year. Forward estimates for MED are not currently available.

Where does ZCoreAI get MED earnings data?

Quotes, earnings and fundamentals come from live ZCoreAI market endpoints and are refreshed on every page load, so the multiple you see reflects the latest reported figures and current price.

MED earnings

Quarterly EPS, revenue, net income and growth for MED.

MED forecast

DCF fair value, price prediction and signal targets for MED.

MED overview

Live chart, fundamentals and valuation context for MED.

MED dividends

Payout history, yield and dividend growth for MED.

Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.